Marchex Seeks Shareholder Approval for Archenia Acquisition, Discloses Financial Projections
MCHX sits 23% above its 52-week low of $1.322 on elevated volume (4.7× avg).
Summary
Marchex is seeking shareholder approval for its acquisition of Archenia, a related-party transaction valued at up to $16.52 million, which includes convertible notes and potential earn-out shares.
Key Events · M&A and Partnerships · MCHX
-
Acquisition Details
Marchex seeks approval to acquire Archenia, a performance-based marketing technology company, for up to $16.52 million. The consideration includes $10 million in convertible promissory notes (convertible at $1.80 per share) and up to 4 million Class B common shares as earn-out consideration.
-
Related-Party Transaction
The sellers of Archenia include Marchex's Chairman, Russell C. Horowitz, and Vice Chairman, Michael Arends. This related-party nature requires approval by a "Majority of the Minority Vote" from disinterested shareholders.
-
Potential Dilution
The earn-out consideration could result in the issuance of up to 4 million Class B shares, representing approximately 10% of current Class B shares outstanding, which is a notable dilutive event.
-
Strategic Rationale
The acquisition aims to integrate Archenia's AI-verified customer qualification and acquisition capabilities with Marchex's existing AI-driven conversation intelligence solutions, expanding product offerings and market opportunities.
Analysis · MCHX · Technology
This preliminary proxy statement details the proposed acquisition of Archenia, Inc. for up to $16.52 million, consisting of convertible notes and potential earn-out shares. The transaction is significant, representing approximately 23% of Marchex's market capitalization, and involves related parties (Marchex's Chairman and Vice Chairman are sellers), necessitating a "Majority of the Minority Vote." The filing provides crucial financial projections for Archenia and a fairness opinion, enabling shareholders to assess the strategic and financial merits of the deal before the July 1, 2026 Special Meeting.
At the time of this filing, MCHX was trading at $1.62 on NASDAQ in the Technology sector, with a market capitalization of approximately $71.8M. The 52-week trading range was $1.32 to $2.31. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.